These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. For better or worse: The effect of levodopa on speech in Parkinson's disease. Ho AK; Bradshaw JL; Iansek R Mov Disord; 2008 Mar; 23(4):574-80. PubMed ID: 18163453 [TBL] [Abstract][Full Text] [Related]
24. [Levodopa as a single treatment of Parkinsonism. Long-term control of 24 cases with discrimination analysis]. Borromei A; Manzini A Minerva Med; 1974 Nov; 65(79):4160-70. PubMed ID: 4610450 [No Abstract] [Full Text] [Related]
25. The impact of treatment with levodopa on Parkinson's disease. Shaw KM; Lees AJ; Stern GM Q J Med; 1980; 49(195):283-93. PubMed ID: 7465763 [TBL] [Abstract][Full Text] [Related]
26. Longitudinal study of the motor response to levodopa in Parkinson's disease. Clissold BG; McColl CD; Reardon KR; Shiff M; Kempster PA Mov Disord; 2006 Dec; 21(12):2116-21. PubMed ID: 17029259 [TBL] [Abstract][Full Text] [Related]
27. Parkinson's disease. Diagnosis and the initiation of therapy. Bhat V; Weiner WJ Minerva Med; 2005 Jun; 96(3):145-54. PubMed ID: 16175158 [TBL] [Abstract][Full Text] [Related]
30. [A family of parkinsonism in which the clinical feature of constituents varied with the age of onset]. Sasaki R; Kuzuhara S; Taniguchi A; Narita Y; Naito Y Rinsho Shinkeigaku; 1994 Jul; 34(7):736-8. PubMed ID: 7955737 [TBL] [Abstract][Full Text] [Related]
31. Glottographic measures before and after levodopa treatment in Parkinson's disease. Jiang J; Lin E; Wang J; Hanson DG Laryngoscope; 1999 Aug; 109(8):1287-94. PubMed ID: 10443835 [TBL] [Abstract][Full Text] [Related]
32. Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions. van Zagten M; Lodder J; Kessels F Mov Disord; 1998 Jan; 13(1):89-95. PubMed ID: 9452332 [TBL] [Abstract][Full Text] [Related]
33. The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group. LeWitt P; Oakes D; Cui L Mov Disord; 1997 Mar; 12(2):183-9. PubMed ID: 9087976 [TBL] [Abstract][Full Text] [Related]
34. Treatment of advanced Parkinson's disease by subthalamotomy: one-year results. Su PC; Tseng HM; Liu HM; Yen RF; Liou HH Mov Disord; 2003 May; 18(5):531-8. PubMed ID: 12722167 [TBL] [Abstract][Full Text] [Related]